Who may be affected: All FDA-regulated product industries and their constituencies will be impacted by the adverse event reporting system changes that provide easier access to raw product safety information
To keep patients safe and outcomes strong, consider the following clinical best practices: Start low, go slow on dosing Monitor for GI symptoms, especially early on Revisit mental health and vision concerns routinely Avoid use in patients with thyroid cancer history Stay alert for signs of pancreatitis or gallbladder issues Smart oversight matters
Ordinary glutathione supplements may become ineffective since nutrients contained within them are destroyed prior to being absorbed
Innovation is in developing formulas with better macros and micros (e.g., creatine, BCAA) to get results faster or formats that ease the eating
Tirzepatide is an injectable medication for weight loss in adults with obesity or overweight
Remember your health is in your hands and staying informed and attentive is your best defense.